Pilot study investigating EAMS as fitness measure in cancer patients
Research type
Research Study
Full title
A pilot study of the utility of body worn electronic activity monitoring systems (EAMS) in determining fitness of patients with cancer
IRAS ID
207657
Contact name
A Anthoney
Contact email
Sponsor organisation
University of Leeds
Duration of Study in the UK
2 years, 0 months, 10 days
Research summary
There is strong evidence showing that the poorer the physical condition of patients with cancer the less likely that treatments, such as chemotherapy, will be effective and the greater the risk of side-effects. Current methods used to assess the fitness of cancer patients have well recognised deficiencies and only give a snap-shot of fitness, usually during an out-patient clinic appointment. This study is a pilot project assessing the acceptability of a widely available commercial electronic activity monitor system (EAMS), worn around the wrist, in helping determine the fitness of patients with cancer who are about to start chemotherapy. Participants will use the EAMS to collect data (including number of steps taken and number of hours slept) over a period of 7 days and this will be compared to data on fitness obtained through currently available standard methods. Information on side effects arising from the first two cycles of chemotherapy treatment received by the participants will also be analysed as well as a repeat assessment of fitness, using the EAMS and standard methods, after two cycles of chemotherapy. The results of the pilot project will inform development of further research.
REC name
London - Central Research Ethics Committee
REC reference
16/LO/1887
Date of REC Opinion
17 Oct 2016
REC opinion
Favourable Opinion